Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - hydrocortisone 1%{relative} (synthesis uses no animal materials);   - topical cream - 1 % - active: hydrocortisone 1%{relative} (synthesis uses no animal materials)   excipient: cetomacrogol 1000 cetostearyl alcohol chlorocresol liquid paraffin purified water white soft paraffin

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - hydrocortisone 1%{relative} - topical cream - 1 % - active: hydrocortisone 1%{relative}

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - hydrocortisone 0.5%{relative} (synthesis uses no animal materials) - topical cream - 0.5 % - active: hydrocortisone 0.5%{relative} (synthesis uses no animal materials) excipient: cetomacrogol 1000 cetostearyl alcohol chlorocresol liquid paraffin purified water white soft paraffin

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - quinine sulfate dihydrate 300mg - film coated tablet - 300 mg - active: quinine sulfate dihydrate 300mg

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - venlafaxine hydrochloride 169.738mg equivalent to venlafaxine 150 mg - modified release capsule - 150 mg - active: venlafaxine hydrochloride 169.738mg equivalent to venlafaxine 150 mg excipient: acryl-eze white 93018508 ethylcellulose gelatin capsule - opaque brown - 0300/2006 hypromellose isopropyl alcohol methylene chloride microcrystalline cellulose povidone purified talc tekprint ink white sb-1018 triethyl citrate - venlafaxine hydrochloride modified release capsules is indicated for the treatment of: · major depression · generalised anxiety disorder · social anxiety disorder · panic disorder. venlafaxine hydrochloride modified release capsules is also indicated for the prevention of relapse and recurrence of major depression where appropriate.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - venlafaxine hydrochloride 84.869mg equivalent to venlafaxine 75 mg - modified release capsule - 75 mg - active: venlafaxine hydrochloride 84.869mg equivalent to venlafaxine 75 mg excipient: acryl-eze white 93018508 ethylcellulose gelatin capsule - pink - 0780/2006 isopropyl alcohol methylene chloride microcrystalline cellulose povidone purified talc tekprint red sb-1018 triethyl citrate - venlafaxine hydrochloride modified release capsules is indicated for the treatment of: · major depression · generalised anxiety disorder · social anxiety disorder · panic disorder. venlafaxine hydrochloride modified release capsules is also indicated for the prevention of relapse and recurrence of major depression where appropriate.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - benzoic acid 5%{relative} - topical solution - 5% w/v - active: benzoic acid 5%{relative}

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - acriflavine 0.1%{relative} - topical solution - 0.1% w/v - active: acriflavine 0.1%{relative}

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - amaranth 10 g; chloroform 200 ml; glycerol 250 ml - solution - 1 % - active: amaranth 10 g chloroform 200 ml glycerol 250 ml

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - paracetamol 4.167%{relative};  ;   - oral suspension - 250 mg/5ml - active: paracetamol 4.167%{relative}     excipient: citric acid glycerol macrogol stearate 400 orange concentrate firmenich purified water saccharin sodium sodium citrate dihydrate sodium cyclamate sodium methyl hydroxybenzoate sorbitol sunset yellow fcf xanthan gum